225 related articles for article (PubMed ID: 27530354)
1. Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.
Takeda S; Himeno T; Kakizoe K; Okazaki H; Okada T; Watanabe K; Aramaki H
J Nat Med; 2017 Jan; 71(1):286-291. PubMed ID: 27530354
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiolic Acid-Mediated Interference with AP-1 Transcriptional Activity in MDA-MB-231 Breast Cancer Cells.
Suzuki M; Takeda S; Okazaki H; Watanabe K; Takiguchi M; Aramaki H
Nat Prod Commun; 2017 May; 12(5):759-761. PubMed ID: 30496661
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.
Hirao-Suzuki M; Takeda S; Koga T; Takiguchi M; Toda A
J Toxicol Sci; 2020; 45(4):227-236. PubMed ID: 32238697
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.
Takeda S; Okazaki H; Ikeda E; Abe S; Yoshioka Y; Watanabe K; Aramaki H
J Toxicol Sci; 2014; 39(5):711-6. PubMed ID: 25242400
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
Takeda S; Okajima S; Miyoshi H; Yoshida K; Okamoto Y; Okada T; Amamoto T; Watanabe K; Omiecinski CJ; Aramaki H
Toxicol Lett; 2012 Nov; 214(3):314-9. PubMed ID: 22963825
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.
Takeda S; Misawa K; Yamamoto I; Watanabe K
Drug Metab Dispos; 2008 Sep; 36(9):1917-21. PubMed ID: 18556441
[TBL] [Abstract][Full Text] [Related]
7. [Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis].
Takeda S
Yakugaku Zasshi; 2013; 133(10):1093-101. PubMed ID: 24088353
[TBL] [Abstract][Full Text] [Related]
8. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
[TBL] [Abstract][Full Text] [Related]
9. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
10. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
11. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
[TBL] [Abstract][Full Text] [Related]
12. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
13. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
14. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
15. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
Li Z; Li D; Li J; Huang P; Qin H
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
17. Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.
Miller ME; Holloway AC; Foster WG
Clin Exp Metastasis; 2005; 22(2):149-56. PubMed ID: 16086235
[TBL] [Abstract][Full Text] [Related]
18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
19. A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition.
Shi XY; Lu H; Li WL; Tang HL; Xiong JJ; Zhang JQ; Opolon P; Legrand C; Perricaudet M; Li H
J Cancer Res Clin Oncol; 2006 Sep; 132(9):561-71. PubMed ID: 16763806
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
